Erik Hedlund

Acting CEO

Since: 2023

Year of birth: 1948

Erik Hedlund has a long career in Ericsson, Siemens Medical and Saab-Scania Combitech, among others before focusing on starting new and developing existing companies, mainly in radiation therapy for cancer. Two of these companies, RaySearch Laboratories AB and C-Rad AB, are traded on Nasdaq Stockholm’s main list. Erik holds a Master of Science in Electrical and Systems Engineering at the Royal Institute of Technology and a degree in Economics from Stockholm university.

Independence: Independent of the Company and the Executive Management and independent of major shareholders.

Board Assignments: Chairman Nolsterby Invest AB, Chairman Oncodia AB and Board member Pharmacolog i Uppsala AB.

Holdings: 1 668 882  shares (indirect).

Photo: Göran Ekeberg

Send download link

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.